Mdm2 Is Required for Inhibition of Cdk2 Activity by p21, Thereby Contributing to p53-Dependent Cell Cycle Arrest
- 1 June 2007
- journal article
- Published by Taylor & Francis Ltd in Molecular and Cellular Biology
- Vol. 27 (11), 4166-4178
- https://doi.org/10.1128/mcb.01967-06
Abstract
P53 is extensively posttranslationally modified in response to various types of cellular stress. Such modifications have been implicated in the regulation of p53 protein levels as well as its DNA binding and transcriptional activities. Treatment of cells with doxorubicin causes phosphorylation and acetylation of p53, transcriptional upregulation of p21 and other target genes, and growth arrest. In contrast, downregulation of Mdm2 by a small interfering RNA (siRNA) approach led to increased levels of p53 lacking phosphorylation at serine 15 and acetylation at lysine 382. Levels of binding of p53 to the p21 promoter were comparable following treatment with doxorubicin or Mdm2 siRNA. Moreover, p53 was transcriptionally active and capable of inducing or repressing a variety of its target genes. Surprisingly, p53 upregulated by Mdm2 siRNA had no effect on cell cycle progression. Although comparable in level to that achieved by treatment with the p53 activators actinomycin D and nutlin-3, the increases in p53 and p21 after downregulation of Mdm2 were not sufficient to trigger cell cycle arrest. This version of p21 was capable of interacting with cyclin-dependent kinase 2 (Cdk2) but failed to inhibit its activity. Taken together, these results argue that Mdm2 is needed for full inhibition of Cdk2 activity by p21, thereby positively contributing to p53-dependent cell cycle arrest.Keywords
This publication has 58 references indexed in Scilit:
- Excess HDM2 Impacts Cell Cycle and Apoptosis and Has a Selective Effect on p53-dependent TranscriptionPublished by Elsevier BV ,2006
- The Intricacies of p21 Phosphorylation: Protein/Protein Interactions, Subcellular Localization and StabilityCell Cycle, 2006
- Limited role of N-terminal phosphoserine residues in the activation of transcription by p53Oncogene, 2004
- MDM2 Is a Negative Regulator of p21 , Independent of p53Published by Elsevier BV ,2004
- p53 Functions through Stress- and Promoter-Specific Recruitment of Transcription Initiation Components before and after DNA DamageMolecular Cell, 2003
- Mutational Analysis of the Cy Motif from p21 Reveals Sequence Degeneracy and Specificity for Different Cyclin-Dependent KinasesMolecular and Cellular Biology, 2001
- TOK-1, a Novel p21Cip1-binding Protein That Cooperatively Enhances p21-dependent Inhibitory Activity toward CDK2 KinasePublished by Elsevier BV ,2000
- An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoOncogene, 2000
- Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathwayOncogene, 1999
- Insensitivity to growth inhibition by TGF-β1 correlates with a lack of inhibition of the CDK2 activity in prostate carcinoma cellsOncogene, 1998